NCT03329755

Optimization of the Patient Care Pathway in Immuno-oncology

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 142 (actual)
• Sponsor: Institut Claudius Regaud · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study compares the care pathway of melanoma patients treated by immunotherapy in two ambulatory care structures. The aim is to measure if a care structure specialized in immuno-oncology could rationalize the care of patients. This protocol will be based on two different follow-up during the treatment period: * dedicated and coordinated e-follow-up (IUCT-O in Toulouse) * standard follow-up (University Hospital Center in Bordeaux) Patients will be followed from the first cycle of immunotherapy until 3 months after the initiation treatment.

Conditions

• Melanoma

Interventions

Type	Name	Description
OTHER	Dedicated and coordinated e-follow-up during the treatment period	* Completion of questionnaires using an electronic tool * Telephone follow-up between the nurse and the patient * Completion of the Quality of Life Questionnaire Core 30 (QLQ-C30)
OTHER	Standard follow-up during the treatment period	\- Completion of the Quality of Life Questionnaire Core 30 (QLQ-C30)

Timeline

• Start date: 2017-12-26
• Primary completion: 2021-02-19
• Completion: 2021-02-19
• First posted: 2017-11-06
• Last updated: 2021-02-24

Locations

2 sites across 1 country: France